Back to search

Article

Discovery of chromatin-based determinants of azacytidine and decitabine anti-cancer activity

2025-08-01

Abstract excerpt

The DNA-incorporating nucleoside analogs azacytidine (AZA) and decitabine (DEC) have clinical efficacy in blood cancers, yet the precise mechanism by which these agents kill cancer cells has remained unresolved -- specifically, whether their anti-tumor activity arises from conventional DNA damage or DNA hypomethylation via DNA methyltransferase 1 (DNMT1) inhibition. This incomplete mechanistic understanding has li...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c8dd79ea-b5ed-549f-a58d-df09da9c0890
DOI
10.1101/2025.07.29.664810
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discovery of chromatin-based determinants of azacytidine and decitabine anti-cancer activityDOI 10.1101/2025.07.29.664810
Select a neighboring publication to make it the new centre.